<p>全球市场正在应对复杂的局面，近期的地缘政治紧张局势和能源市场波动影响了投资者情绪。在这种背景下，便宜股成为寻求低价增长潜力的投资者的有趣机会。尽管 “便宜股” 这个术语可能显得过时，但这些较小或较新的公司在强大的财务支持和明确的增长前景下可以提供可观的价值。</p>
<h3>全球十大便宜股</h3>
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名称</strong></td>
<td><strong>股价</strong></td>
<td><strong>市值</strong></td>
<td><strong>收益与风险</strong></td>
</tr>
<tr>
<td>北东橡胶 (SET:NER)</td>
<td>THB4.88</td>
<td>THB9.02B</td>
<td>✅ 5 ⚠️ 2 查看分析 </td>
</tr>
<tr>
<td>亚洲医学与农业实验室及研究中心 (SET:AMARC)</td>
<td>THB3.40</td>
<td>THB1.42B</td>
<td>✅ 3 ⚠️ 3 查看分析 </td>
</tr>
<tr>
<td>前瞻集团控股 (LSE:FSG)</td>
<td>£3.745</td>
<td>£425.41M</td>
<td>✅ 5 ⚠️ 0 查看分析 </td>
</tr>
<tr>
<td>Angler Gaming (NGM:ANGL)</td>
<td>SEK3.60</td>
<td>SEK269.95M</td>
<td>✅ 4 ⚠️ 2 查看分析 </td>
</tr>
<tr>
<td>Angler Gaming (DB:0QM)</td>
<td>€0.31</td>
<td>€239.95M</td>
<td>✅ 4 ⚠️ 3 查看分析 </td>
</tr>
<tr>
<td>PC Partner Group (SGX:PCT)</td>
<td>SGD1.58</td>
<td>SGD612.86M</td>
<td>✅ 4 ⚠️ 2 查看分析 </td>
</tr>
<tr>
<td>CNMC Goldmine Holdings (Catalist:5TP)</td>
<td>SGD1.53</td>
<td>SGD620.09M</td>
<td>✅ 4 ⚠️ 2 查看分析 </td>
</tr>
<tr>
<td>Focus Point Holdings Berhad (KLSE:FOCUSP)</td>
<td>MYR0.485</td>
<td>MYR298.25M</td>
<td>✅ 5 ⚠️ 2 查看分析 </td>
</tr>
<tr>
<td>扬子江造船 (SGX:BS6)</td>
<td>SGD3.99</td>
<td>SGD15.7B</td>
<td>✅ 4 ⚠️ 2 查看分析 </td>
</tr>
<tr>
<td>综合诊断控股 (LSE:IDHC)</td>
<td>$0.61</td>
<td>$354.61M</td>
<td>✅ 4 ⚠️ 1 查看分析 </td>
</tr>
</tbody>
</table>
<p>点击这里查看我们全球便宜股筛选器中的 3469 只股票的完整列表。</p>
<p>我们将查看筛选工具中的一些最佳选择。</p>
<h2>中珠医疗控股有限公司 (SHSE:600568)</h2>
<p><strong>Simply Wall St 财务健康评级：</strong> ★★★★★★</p>
<p><strong>概述：</strong> 中珠医疗控股有限公司专注于中国药物的研究、开发、生产和销售，市值为人民币 54.8 亿元。</p>
<p><strong>运营：</strong> 该公司在中国的运营收入为人民币 5.7062 亿元。</p>
<p><strong>市值：</strong> 人民币 54.8 亿</p>
<p>中珠医疗控股有限公司市值为人民币 54.8 亿元，收入为人民币 5.7062 亿元，且无债务，现金流足以支撑超过三年的运营，尽管尚未盈利。公司的管理层和董事会相对较新，平均任期为 1.3 年，表明可能会有战略转变。最近的进展包括由共青城美华腾龙启飞投资合伙企业收购 10.38% 的股份，交易金额约为人民币 4 亿元，尽管面临持续的盈利挑战和-32.97% 的负股本回报率，但仍显示出投资者的兴趣。</p>
<ul>
<li>通过我们的综合资产负债表健康报告深入了解中珠医疗控股有限公司的复杂性。</li>
<li>查看中珠医疗控股有限公司的历史业绩报告，以了解其在过去几年的表现。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/0a3cf580-900f-46c8-851b-02eca26e9944/chart/financial-position-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/0a3cf580-900f-46c8-851b-02eca26e9944/chart/financial-position-analysis"/></p>
<p>SHSE:600568 财务状况分析截至 2026 年 4 月</p>
<h2>南方泵业 (SZSE:300145)</h2>
<p><strong>Simply Wall St 财务健康评级：</strong> ★★★★★☆</p>
<p><strong>概述：</strong> 南方泵业有限公司从事泵产品的研究、设计、开发、生产和销售，市值为人民币 86.3 亿元。</p>
<p><strong>运营：</strong> 南方泵业有限公司未报告具体的收入细分。</p>
<p><strong>市值：</strong> 人民币 86.3 亿</p>
<p>南方泵业有限公司市值为人民币 86.3 亿元，在过去五年中表现出持续的盈利增长，年均增长 67.1%，尽管最近的增长放缓至 5.9%。尽管最新财务结果受到 1.083 亿元的一次性损失影响，但公司仍保持财务稳定，短期资产为 55 亿元，超过短期和长期负债。其净债务与股本比率为 37.4%，利息覆盖率良好，得益于充足的盈利表现。公司的市盈率为 34.5 倍，低于中国市场平均水平。</p>
<ul>
<li>点击这里查看完整的分析健康报告，以更深入了解南方泵业。</li>
<li>通过查看我们的增长报告，了解南方泵业的盈利前景。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/c1415cd4-7614-4b7e-9fe7-b95f444bf490/chart/financial-position-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/c1415cd4-7614-4b7e-9fe7-b95f444bf490/chart/financial-position-analysis"/></p>
<p>SZSE:300145 财务状况分析截至 2026 年 4 月</p>
<h2>物通控股集团 (SZSE:300292)</h2>
<p><strong>Simply Wall St 财务健康评级：</strong> ★★★★★★</p>
<p><strong>概述：</strong> 物通控股集团有限公司在中国制造和销售智能通信设备，市值为人民币 64.9 亿元。</p>
<p><strong>运营：</strong> 该公司未报告任何具体的收入细分。</p>
<p><strong>市值：</strong> 人民币 64.9 亿</p>
<p>物通控股集团市值为人民币 64.9 亿元，过去一年表现出 121.8% 的显著盈利增长，超过了通信行业。公司的债务与股本比率在五年内显著改善，从 44.2% 降至 16.8%，且现金超过总债务，表明财务健康良好。其市盈率为 62.8 倍，低于行业平均水平，尽管其股本回报率较低，仅为 8.1%。短期资产足以覆盖负债，利息支付也得到了 EBIT（24 倍）的良好覆盖。</p>
<ul>
<li>在我们的财务健康报告中更深入地了解物通控股集团的潜力。</li>
<li>查看我们的历史业绩报告，以获取物通控股集团的业绩记录。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/60afb4ed-6349-4e73-8644-08bda46406fb/chart/financial-position-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/60afb4ed-6349-4e73-8644-08bda46406fb/chart/financial-position-analysis"/></p>
<p>SZSE:300292 财务状况分析截至 2026 年 4 月</p>
<h2>关键要点</h2>
<ul>
<li>解锁更多宝藏！我们的全球便宜股票筛选器为您挖掘了 3466 家更多公司供您探索。点击这里揭开我们精心策划的 3469 家全球便宜股票名单。</li>
<li>对其他选择感兴趣？通过稳健的分红支付者来多样化您的投资组合，以提供可靠的收入来源，以应对潜在的市场动荡。</li>
</ul>
<p><em>这篇文章由 Simply Wall St 撰写，内容具有一般性。<strong>我们提供基于历史数据和分析师预测的评论，采用无偏见的方法，我们的文章并不构成财务建议。</strong> 它不构成买入或卖出任何股票的推荐，也未考虑您的目标或财务状况。我们的目标是为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。</em></p>
<h3>估值是复杂的，但我们在这里为您简化。</h3>
<p>通过我们的详细分析，发现南方泵业是否被低估或高估，分析内容包括 <strong>公允价值估计、潜在风险、分红、内部交易及其财务状况。</strong></p>
<p>获取免费分析</p>

ST中珠

<p>中珠医疗控股有限公司是一家市值为 54.8 亿人民币的低价股，专注于中国的药物开发。尽管尚未盈利，但公司拥有足够的现金流，并且最近通过收购 10.38% 的股份吸引了投资者的关注。该公司实现了 5.7062 亿人民币的收入，但股本回报率为-32.97%。文章还强调了其他低价股，包括南方泵业和五通控股集团，展示了它们在市场波动中财务健康和增长潜力</p>

<p>Global markets have been navigating a complex landscape, with recent geopolitical tensions and energy market volatility influencing investor sentiment. Against this backdrop, penny stocks emerge as intriguing opportunities for investors seeking growth potential at lower price points. Although the term &#34;penny stocks&#34; may seem outdated, these smaller or newer companies can offer substantial value when supported by strong financials and clear growth prospects.</p>
<div class="lb-trans"><p>全球市场正在应对复杂的局面，近期的地缘政治紧张局势和能源市场波动影响了投资者情绪。在这种背景下，便宜股成为寻求低价增长潜力的投资者的有趣机会。尽管 “便宜股” 这个术语可能显得过时，但这些较小或较新的公司在强大的财务支持和明确的增长前景下可以提供可观的价值。</p>
</div><h3>Top 10 Penny Stocks Globally</h3>
<div class="lb-trans"><h3>全球十大便宜股</h3>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Name</strong></td>
<td><strong>Share Price</strong></td>
<td><strong>Market Cap</strong></td>
<td><strong>Rewards &amp; Risks</strong></td>
</tr>
<tr>
<td>North East Rubber (SET:NER)</td>
<td>THB4.88</td>
<td>THB9.02B</td>
<td>✅ 5 ⚠️ 2 View Analysis &gt;</td>
</tr>
<tr>
<td>Asia Medical and Agricultural Laboratory and Research Center (SET:AMARC)</td>
<td>THB3.40</td>
<td>THB1.42B</td>
<td>✅ 3 ⚠️ 3 View Analysis &gt;</td>
</tr>
<tr>
<td>Foresight Group Holdings (LSE:FSG)</td>
<td>£3.745</td>
<td>£425.41M</td>
<td>✅ 5 ⚠️ 0 View Analysis &gt;</td>
</tr>
<tr>
<td>Angler Gaming (NGM:ANGL)</td>
<td>SEK3.60</td>
<td>SEK269.95M</td>
<td>✅ 4 ⚠️ 2 View Analysis &gt;</td>
</tr>
<tr>
<td>Angler Gaming (DB:0QM)</td>
<td>€0.31</td>
<td>€239.95M</td>
<td>✅ 4 ⚠️ 3 View Analysis &gt;</td>
</tr>
<tr>
<td>PC Partner Group (SGX:PCT)</td>
<td>SGD1.58</td>
<td>SGD612.86M</td>
<td>✅ 4 ⚠️ 2 View Analysis &gt;</td>
</tr>
<tr>
<td>CNMC Goldmine Holdings (Catalist:5TP)</td>
<td>SGD1.53</td>
<td>SGD620.09M</td>
<td>✅ 4 ⚠️ 2 View Analysis &gt;</td>
</tr>
<tr>
<td>Focus Point Holdings Berhad (KLSE:FOCUSP)</td>
<td>MYR0.485</td>
<td>MYR298.25M</td>
<td>✅ 5 ⚠️ 2 View Analysis &gt;</td>
</tr>
<tr>
<td>Yangzijiang Shipbuilding (Holdings) (SGX:BS6)</td>
<td>SGD3.99</td>
<td>SGD15.7B</td>
<td>✅ 4 ⚠️ 2 View Analysis &gt;</td>
</tr>
<tr>
<td>Integrated Diagnostics Holdings (LSE:IDHC)</td>
<td>$0.61</td>
<td>$354.61M</td>
<td>✅ 4 ⚠️ 1 View Analysis &gt;</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名称</strong></td>
<td><strong>股价</strong></td>
<td><strong>市值</strong></td>
<td><strong>收益与风险</strong></td>
</tr>
<tr>
<td>北东橡胶 (SET:NER)</td>
<td>THB4.88</td>
<td>THB9.02B</td>
<td>✅ 5 ⚠️ 2 查看分析 </td>
</tr>
<tr>
<td>亚洲医学与农业实验室及研究中心 (SET:AMARC)</td>
<td>THB3.40</td>
<td>THB1.42B</td>
<td>✅ 3 ⚠️ 3 查看分析 </td>
</tr>
<tr>
<td>前瞻集团控股 (LSE:FSG)</td>
<td>£3.745</td>
<td>£425.41M</td>
<td>✅ 5 ⚠️ 0 查看分析 </td>
</tr>
<tr>
<td>Angler Gaming (NGM:ANGL)</td>
<td>SEK3.60</td>
<td>SEK269.95M</td>
<td>✅ 4 ⚠️ 2 查看分析 </td>
</tr>
<tr>
<td>Angler Gaming (DB:0QM)</td>
<td>€0.31</td>
<td>€239.95M</td>
<td>✅ 4 ⚠️ 3 查看分析 </td>
</tr>
<tr>
<td>PC Partner Group (SGX:PCT)</td>
<td>SGD1.58</td>
<td>SGD612.86M</td>
<td>✅ 4 ⚠️ 2 查看分析 </td>
</tr>
<tr>
<td>CNMC Goldmine Holdings (Catalist:5TP)</td>
<td>SGD1.53</td>
<td>SGD620.09M</td>
<td>✅ 4 ⚠️ 2 查看分析 </td>
</tr>
<tr>
<td>Focus Point Holdings Berhad (KLSE:FOCUSP)</td>
<td>MYR0.485</td>
<td>MYR298.25M</td>
<td>✅ 5 ⚠️ 2 查看分析 </td>
</tr>
<tr>
<td>扬子江造船 (SGX:BS6)</td>
<td>SGD3.99</td>
<td>SGD15.7B</td>
<td>✅ 4 ⚠️ 2 查看分析 </td>
</tr>
<tr>
<td>综合诊断控股 (LSE:IDHC)</td>
<td>$0.61</td>
<td>$354.61M</td>
<td>✅ 4 ⚠️ 1 查看分析 </td>
</tr>
</tbody>
</table>
</div><p>Click here to see the full list of 3,469 stocks from our Global Penny Stocks screener.</p>
<div class="lb-trans"><p>点击这里查看我们全球便宜股筛选器中的 3469 只股票的完整列表。</p>
</div><p>We're going to check out a few of the best picks from our screener tool.</p>
<div class="lb-trans"><p>我们将查看筛选工具中的一些最佳选择。</p>
</div><h2>Zhongzhu Healthcare HoldingLtd (SHSE:600568)</h2>
<div class="lb-trans"><h2>中珠医疗控股有限公司 (SHSE:600568)</h2>
</div><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★★★</p>
<div class="lb-trans"><p><strong>Simply Wall St 财务健康评级：</strong> ★★★★★★</p>
</div><p><strong>Overview:</strong> Zhongzhu Healthcare Holding Co., Ltd focuses on the research, development, production, and sale of drugs in China with a market capitalization of CN¥5.48 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> 中珠医疗控股有限公司专注于中国药物的研究、开发、生产和销售，市值为人民币 54.8 亿元。</p>
</div><p><strong>Operations:</strong> The company generates CN¥570.62 million in revenue from its operations within China.</p>
<div class="lb-trans"><p><strong>运营：</strong> 该公司在中国的运营收入为人民币 5.7062 亿元。</p>
</div><p><strong>Market Cap:</strong> CN¥5.48B</p>
<div class="lb-trans"><p><strong>市值：</strong> 人民币 54.8 亿</p>
</div><p>Zhongzhu Healthcare Holding Co., Ltd, with a market cap of CN¥5.48 billion and revenue of CN¥570.62 million, is debt-free and has a sufficient cash runway exceeding three years despite being unprofitable. The company's management and board are relatively new, with an average tenure of 1.3 years, indicating potential for strategic shifts. Recent developments include the acquisition of a 10.38% stake by Gongqingcheng Meihua Tenglong Qifei Investment Partnership Enterprise for approximately CN¥400 million, signaling investor interest despite ongoing profitability challenges and negative return on equity at -32.97%.</p>
<div class="lb-trans"><p>中珠医疗控股有限公司市值为人民币 54.8 亿元，收入为人民币 5.7062 亿元，且无债务，现金流足以支撑超过三年的运营，尽管尚未盈利。公司的管理层和董事会相对较新，平均任期为 1.3 年，表明可能会有战略转变。最近的进展包括由共青城美华腾龙启飞投资合伙企业收购 10.38% 的股份，交易金额约为人民币 4 亿元，尽管面临持续的盈利挑战和-32.97% 的负股本回报率，但仍显示出投资者的兴趣。</p>
</div><ul>
<li>Navigate through the intricacies of Zhongzhu Healthcare HoldingLtd with our comprehensive balance sheet health report here.</li>
<li>Examine Zhongzhu Healthcare HoldingLtd's past performance report to understand how it has performed in prior years.</li>
</ul>
<div class="lb-trans"><ul>
<li>通过我们的综合资产负债表健康报告深入了解中珠医疗控股有限公司的复杂性。</li>
<li>查看中珠医疗控股有限公司的历史业绩报告，以了解其在过去几年的表现。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/0a3cf580-900f-46c8-851b-02eca26e9944/chart/financial-position-analysis" alt="" original-src="https://images.simplywall.st/company/0a3cf580-900f-46c8-851b-02eca26e9944/chart/financial-position-analysis"/></p>
<p>SHSE:600568 Financial Position Analysis as at Apr 2026</p>
<div class="lb-trans"><p>SHSE:600568 财务状况分析截至 2026 年 4 月</p>
</div><h2>Nanfang Pump Industry (SZSE:300145)</h2>
<div class="lb-trans"><h2>南方泵业 (SZSE:300145)</h2>
</div><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★★☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 财务健康评级：</strong> ★★★★★☆</p>
</div><p><strong>Overview:</strong> Nanfang Pump Industry Co., Ltd. is involved in the research, design, development, production, and sale of pump products both in China and internationally, with a market cap of CN¥8.63 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> 南方泵业有限公司从事泵产品的研究、设计、开发、生产和销售，市值为人民币 86.3 亿元。</p>
</div><p><strong>Operations:</strong> No specific revenue segments are reported for Nanfang Pump Industry Co., Ltd.</p>
<div class="lb-trans"><p><strong>运营：</strong> 南方泵业有限公司未报告具体的收入细分。</p>
</div><p><strong>Market Cap:</strong> CN¥8.63B</p>
<div class="lb-trans"><p><strong>市值：</strong> 人民币 86.3 亿</p>
</div><p>Nanfang Pump Industry Co., Ltd., with a market cap of CN¥8.63 billion, has demonstrated consistent earnings growth over the past five years, averaging 67.1% annually, although recent growth slowed to 5.9%. Despite a large one-off loss of CN¥108.3 million affecting its latest financial results, the company remains financially stable with short-term assets of CN¥5.5 billion exceeding both short and long-term liabilities. Its net debt to equity ratio is satisfactory at 37.4%, and interest coverage is not an issue due to adequate earnings performance. The company's Price-to-Earnings ratio stands at 34.5x, below the Chinese market average.</p>
<div class="lb-trans"><p>南方泵业有限公司市值为人民币 86.3 亿元，在过去五年中表现出持续的盈利增长，年均增长 67.1%，尽管最近的增长放缓至 5.9%。尽管最新财务结果受到 1.083 亿元的一次性损失影响，但公司仍保持财务稳定，短期资产为 55 亿元，超过短期和长期负债。其净债务与股本比率为 37.4%，利息覆盖率良好，得益于充足的盈利表现。公司的市盈率为 34.5 倍，低于中国市场平均水平。</p>
</div><ul>
<li>Jump into the full analysis health report here for a deeper understanding of Nanfang Pump Industry.</li>
<li>Understand Nanfang Pump Industry's earnings outlook by examining our growth report.</li>
</ul>
<div class="lb-trans"><ul>
<li>点击这里查看完整的分析健康报告，以更深入了解南方泵业。</li>
<li>通过查看我们的增长报告，了解南方泵业的盈利前景。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/c1415cd4-7614-4b7e-9fe7-b95f444bf490/chart/financial-position-analysis" alt="" original-src="https://images.simplywall.st/company/c1415cd4-7614-4b7e-9fe7-b95f444bf490/chart/financial-position-analysis"/></p>
<p>SZSE:300145 Financial Position Analysis as at Apr 2026</p>
<div class="lb-trans"><p>SZSE:300145 财务状况分析截至 2026 年 4 月</p>
</div><h2>Wutong Holding Group (SZSE:300292)</h2>
<div class="lb-trans"><h2>物通控股集团 (SZSE:300292)</h2>
</div><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★★★</p>
<div class="lb-trans"><p><strong>Simply Wall St 财务健康评级：</strong> ★★★★★★</p>
</div><p><strong>Overview:</strong> Wutong Holding Group Co., Ltd. manufactures and sells intelligent telecommunication devices in China and has a market cap of CN¥6.49 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> 物通控股集团有限公司在中国制造和销售智能通信设备，市值为人民币 64.9 亿元。</p>
</div><p><strong>Operations:</strong> The company has not reported any specific revenue segments.</p>
<div class="lb-trans"><p><strong>运营：</strong> 该公司未报告任何具体的收入细分。</p>
</div><p><strong>Market Cap:</strong> CN¥6.49B</p>
<div class="lb-trans"><p><strong>市值：</strong> 人民币 64.9 亿</p>
</div><p>Wutong Holding Group, with a market cap of CN¥6.49 billion, has shown impressive earnings growth of 121.8% over the past year, outpacing the Communications industry. The company's debt to equity ratio has significantly improved from 44.2% to 16.8% in five years, and it holds more cash than total debt, indicating strong financial health. Its Price-to-Earnings ratio of 62.8x is below the industry average, suggesting potential value for investors despite its low Return on Equity at 8.1%. Short-term assets comfortably cover liabilities, and interest payments are well covered by EBIT (24x).</p>
<div class="lb-trans"><p>物通控股集团市值为人民币 64.9 亿元，过去一年表现出 121.8% 的显著盈利增长，超过了通信行业。公司的债务与股本比率在五年内显著改善，从 44.2% 降至 16.8%，且现金超过总债务，表明财务健康良好。其市盈率为 62.8 倍，低于行业平均水平，尽管其股本回报率较低，仅为 8.1%。短期资产足以覆盖负债，利息支付也得到了 EBIT（24 倍）的良好覆盖。</p>
</div><ul>
<li>Take a closer look at Wutong Holding Group's potential here in our financial health report.</li>
<li>Review our historical performance report to gain insights into Wutong Holding Group's track record.</li>
</ul>
<div class="lb-trans"><ul>
<li>在我们的财务健康报告中更深入地了解物通控股集团的潜力。</li>
<li>查看我们的历史业绩报告，以获取物通控股集团的业绩记录。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/60afb4ed-6349-4e73-8644-08bda46406fb/chart/financial-position-analysis" alt="" original-src="https://images.simplywall.st/company/60afb4ed-6349-4e73-8644-08bda46406fb/chart/financial-position-analysis"/></p>
<p>SZSE:300292 Financial Position Analysis as at Apr 2026</p>
<div class="lb-trans"><p>SZSE:300292 财务状况分析截至 2026 年 4 月</p>
</div><h2>Key Takeaways</h2>
<div class="lb-trans"><h2>关键要点</h2>
</div><ul>
<li>Unlock more gems! Our Global Penny Stocks screener has unearthed 3,466 more companies for you to explore.Click here to unveil our expertly curated list of 3,469 Global Penny Stocks.</li>
<li>Curious About Other Options? Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.</li>
</ul>
<div class="lb-trans"><ul>
<li>解锁更多宝藏！我们的全球便宜股票筛选器为您挖掘了 3466 家更多公司供您探索。点击这里揭开我们精心策划的 3469 家全球便宜股票名单。</li>
<li>对其他选择感兴趣？通过稳健的分红支付者来多样化您的投资组合，以提供可靠的收入来源，以应对潜在的市场动荡。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.</em></p>
<div class="lb-trans"><p><em>这篇文章由 Simply Wall St 撰写，内容具有一般性。<strong>我们提供基于历史数据和分析师预测的评论，采用无偏见的方法，我们的文章并不构成财务建议。</strong> 它不构成买入或卖出任何股票的推荐，也未考虑您的目标或财务状况。我们的目标是为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。</em></p>
</div><h3>Valuation is complex, but we're here to simplify it.</h3>
<div class="lb-trans"><h3>估值是复杂的，但我们在这里为您简化。</h3>
</div><p>Discover if Nanfang Pump Industry might be undervalued or overvalued with our detailed analysis, featuring <strong>fair value estimates, potential risks, dividends, insider trades, and its financial condition.</strong></p>
<div class="lb-trans"><p>通过我们的详细分析，发现南方泵业是否被低估或高估，分析内容包括 <strong>公允价值估计、潜在风险、分红、内部交易及其财务状况。</strong></p>
</div><p>Access Free Analysis</p>
<div class="lb-trans"><p>获取免费分析</p>
</div>

探索全球便士股：中珠医疗控股有限公司领衔我们的三人组